PSIL - AdvisorShares Psychedelics ETF
This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more of their assets to, psychedelic compounds, their derivatives, or other financial instruments exhibiting similar economic characteristics. The fund's primary holdings consist of publicly traded life sciences firms focused on psychedelic medical treatments, in addition to other businesses involved in the broader psychedelics sector.
As of Nov 13, 2026: spot at $19.33, ATM IV 53.1%, max pain $20.00, GEX (assumed dealer book) $380 of delta per 1% move.
Exposures are the assumed dealer book over the expirations within 30 days of the session, or the first four when none are (1 expiration, through Nov 20, 2026), as of Nov 13, 2026. Assumes dealers are long the calls and short the puts, a share p of open interest each - here 100% of open interest (the GEX page sets the share). A date without a stored exposure is a gap; a value marked * is partial, averaged over fewer days, or may include contracts expiring that day or of an unreadable expiration: its reason is printed beside it.
- Sector
- Financial Services
- Industry
- Asset Management
- Market Cap
- $19.5M
- Beta
- 0.56
- 52-Week Range
- 15.63-27.02
- Dividend Yield
- $1.88
- IPO Date
- Sep 16, 2021
- Exchange
- AMEX
What PSIL Looks Like to Options Traders Today
IV rank of 21.9% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); the assumed dealer book's GEX is positive ($380 of delta per 1% move): its hedging leans against the trend, damping realized volatility where real dealers are positioned like the book; the 25-delta skew (0.022) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The PSIL overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.
PSIL fund facts: expense ratio 1.28%, assets under management $41.9M, NAV $19.44 as of the data source's update on Nov 13, 2026, 29 holdings in its latest file, launched Sep 15, 2021, issued by AdvisorShares. See the PSIL holdings.
Frequently asked PSIL overview questions
- What is PSIL?
- PSIL is the ticker symbol for AdvisorShares Psychedelics ETF, an listed exchange-traded fund. This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more of their assets to, psychedelic compounds, their derivatives, or other financial instruments exhibiting similar economic characteristics. Listed on AMEX. PSIL is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
- What does the PSIL options snapshot look like today?
- As of Nov 13, 2026, the PSIL options snapshot shows spot at $19.33, ATM IV 53.1%, IV rank 21.9%, max pain $20.00, GEX (assumed dealer book) $380 of delta per 1% move, expected move 15.22%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, the assumed dealer book's gamma exposure and the put-minus-call delta balance, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are PSIL's key statistics?
- AdvisorShares Psychedelics ETF (PSIL) carries a market capitalization of $19.5M, 52-week range of 15.63-27.02. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
- What sector or industry does PSIL belong to?
- AdvisorShares Psychedelics ETF operates in the Financial Services sector, in the Asset Management industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare PSIL's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the PSIL data on this page?
- The options snapshot above is dated Nov 13, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.